Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan (vol 37, pg 3850, 2020)

被引：1
|
作者：
Takahashi, Shunji [1 ]
Tahara, Makoto [2 ]
Ito, Koichi [3 ]
Tori, Masayuki [4 ]
Kiyota, Naomi [5 ]
Yoshida, Katsutoshi [6 ]
Sakata, Yukinori [6 ]
Yoshida, Akira [7 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan
[2] Natl Canc Ctr Hosp East, Dept Head & Neck Canc Oncol, Kashiwa, Chiba 2778577, Japan
[3] Ito Hosp, Shibuya Ku, 4-3-6 Jingu Mae, Tokyo 1508308, Japan
[4] Osaka Police Hosp, Dept Endocrine Surg, Tennouji Ku, 10-31 Kitayamacho, Osaka 5430035, Japan
[5] Kobe Univ Hosp, Ctr Canc, Oncol Hematol, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan
[6] Eisai & Co Ltd, Bunkyo Ku, 4-6-10 Koishikawa, Tokyo 1128088, Japan
[7] Kanagawa Hlth Serv Assoc, Naka Ku, Nihon Odori Bldg,58 Nihon Odori, Yokohama, Kanagawa 2310021, Japan
来源：
ADVANCES IN THERAPY | 2021年 / 38卷 / 09期
关键词：
D O I：
10.1007/s12325-021-01829-0
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：4989 / 4993
页数：5
相关论文
共 50 条
  • [1] Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Shunji Takahashi
    Makoto Tahara
    Koichi Ito
    Masayuki Tori
    Naomi Kiyota
    Katsutoshi Yoshida
    Yukinori Sakata
    Akira Yoshida
    [J]. Advances in Therapy, 2020, 37 : 3850 - 3862
  • [2] Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Takahashi, Shunji
    Tahara, Makoto
    Ito, Koichi
    Tori, Masayuki
    Kiyota, Naomi
    Yoshida, Katsutoshi
    Sakata, Yukinori
    Yoshida, Akira
    [J]. ADVANCES IN THERAPY, 2020, 37 (09) : 3850 - 3862
  • [3] Correction to: Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Shunji Takahashi
    Makoto Tahara
    Koichi Ito
    Masayuki Tori
    Naomi Kiyota
    Katsutoshi Yoshida
    Yukinori Sakata
    Akira Yoshida
    [J]. Advances in Therapy, 2021, 38 : 4989 - 4993
  • [4] Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan
    Furuse, Junji
    Izumi, Namiki
    Motomura, Kenta
    Inaba, Yoshitaka
    Katamura, Yoshio
    Kondo, Yasuteru
    Yabushita, Kazuhisa
    Motoyoshi, Katsuaki
    Kudo, Masatoshi
    [J]. DRUGS-REAL WORLD OUTCOMES, 2023, 10 (02) : 195 - 205
  • [5] Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan
    Junji Furuse
    Namiki Izumi
    Kenta Motomura
    Yoshitaka Inaba
    Yoshio Katamura
    Yasuteru Kondo
    Kazuhisa Yabushita
    Katsuaki Motoyoshi
    Masatoshi Kudo
    [J]. Drugs - Real World Outcomes, 2023, 10 : 195 - 205
  • [6] Drug use investigation on the safety and efficacy of tigecycline in Japan (all-case post-marketing surveillance)
    Ohashi, Takahisa
    Sugiyama, Noriko
    Watanabe, Toshiya
    Uryu, Taku
    Yoshinaga, Yukari
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (07) : 866 - 874
  • [7] Safety Profile of Ixazomib in Patients with Relapsed/Refractory Multiple Myeloma in Japan: An All-case Post-marketing Surveillance
    Kakimoto, Yoshihide
    Hoshino, Miyako
    Hashimoto, Mikiko
    Hiraizumi, Masaya
    Shimizu, Kohei
    Chou, Takaaki
    [J]. INTERNAL MEDICINE, 2022, 61 (09) : 1337 - 1343
  • [8] Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study
    Kang, Wonseok
    Kim, Yoon Jun
    Kim, Seung Up
    Seo, Yeon Seok
    Kim, Jin-Wook
    Kim, Ji Hoon
    Park, Soo Young
    Baek, Yang-Hyun
    Kim, Kang Mo
    Lee, Hae Lim
    Yoon, Ki Tae
    Kim, Hyeyeong
    Cheong, Jae Youn
    Hwang, Jae Seok
    Kim, Ju Hyun
    Kim, Kwang Min
    Sung, Pil Soo
    Kim, Jieun
    Kim, Do Young
    [J]. FUTURE ONCOLOGY, 2024,
  • [9] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Chen, Yucherng
    Katayose, Taeko
    Nagaoka, Soshi
    Piao, Yongzhe
    Yamaguchi, Kensei
    Asou, Hiroya
    [J]. GASTRIC CANCER, 2021, 24 (06) : 1320 - 1329
  • [10] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Yucherng Chen
    Taeko Katayose
    Soshi Nagaoka
    Yongzhe Piao
    Kensei Yamaguchi
    Hiroya Asou
    [J]. Gastric Cancer, 2021, 24 : 1320 - 1329
12345